Delpor Revenue and Competitors
Estimated Revenue & Valuation
- Delpor's estimated annual revenue is currently $1M per year.
- Delpor's estimated revenue per employee is $77,500
- Delpor's total funding is $4.9M.
Employee Data
- Delpor has 13 Employees.
- Delpor grew their employee count by -41% last year.
Delpor's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
3 | Senior R&D Engineering Manager | Reveal Email/Phone |
4 | Finance Accounting Manager | Reveal Email/Phone |
5 | R&D Engineer | Reveal Email/Phone |
6 | Research Associate | Reveal Email/Phone |
7 | Research Associate | Reveal Email/Phone |
8 | Manufacturing Specialist | Reveal Email/Phone |
Delpor Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.3M | 21 | 31% | N/A | N/A |
What Is Delpor?
Delpor is a clinical stage life sciences company that utilizes innovative drug-delivery technologies in order to develop once-yearly therapies for chronic conditions. The Company’s lead product is a 6-12-month formulation of Risperidone (drug/device combination product) for the treatment of schizophrenia. Delpor is also pursuing 6-12 month formulations of other drugs targeting CNS conditions including Neuromuscular Diseases, Neurodegenerative Diseases, Addiction, and other disorders.
keywords:N/A
$4.9M
Total Funding
13
Number of Employees
$1M
Revenue (est)
-41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Delpor News
2022-04-20 - Micro Chemotherapy Market Size, Scope And Forecast ...
... And Forecast | Amgen, Celgene, MagForce AG, Nanotherapeutics, Spectrum Pharmaceuticals, Ablynx, AMAG, CytImmune, Delpor, Nanospectra.
Other Companies in Brisbane
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 13 | -32% | N/A |
#2 | $1.1M | 13 | -7% | N/A |
#3 | $1.3M | 13 | 8% | N/A |
#4 | N/A | 13 | 117% | N/A |
#5 | N/A | 13 | N/A | N/A |